Physician profile
Kulpreet Barn
NPI 1699064600
$91,605.51
in general payments reported to CMS, 2019-2025
28 companies · $4,257 in 2025
The $4,257 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $2,777 · 2021: $14K · 2022: $21K · 2023: $21K · 2024: $28K · 2025: $4,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $6,397 · Travel and Lodging: $2,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,215.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,125.00 |
| Food and Beverage | $6,397.25 |
| Travel and Lodging | $2,028.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $56,914.95 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $16,294.66 | 2023-2025 | Farxiga |
| Pfizer INC. | $14,824.09 | 2020-2025 | |
| Abiomed | $613.74 | 2024-2025 | Impella |
| Biotronik INC. | $574.60 | 2021-2024 | Amvia Edge, Acticor 7 Vr-T Dx |
| Alnylam Pharmaceuticals INC. | $393.30 | 2024-2025 | Amvuttra, Onpattro |
| Actelion Pharmaceuticals US, INC. | $374.30 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Edwards Lifesciences Corporation | $239.67 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $202.49 | 2022-2025 | Bodyguardian, Watchman Flx |
| Bridgebio Pharma, INC. | $197.77 | 2025 | Attruby |
| Cvrx, INC. | $197.58 | 2024-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.05 | 2020-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $93.66 | 2023-2025 | Verquvo |
| Cardiac Dimensions, INC. | $76.68 | 2022-2024 | |
| Impulse Dynamics (USA) INC. | $72.06 | 2025 | Optimizer |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $63.29 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $61.42 | 2024-2025 | Camzyos, Eliquis |
| Eurofins Viracor, LLC | $57.98 | 2025 | |
| Novartis Pharmaceuticals Corporation | $36.20 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.87 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $33.60 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $30.47 | 2024 | Arcalyst |
| One Lambda, INC. | $26.06 | 2025 | |
| Endotronix, INC. | $21.30 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Scpharmaceuticals INC. | $20.50 | 2025 | |
| Daiichi Sankyo INC. | $19.00 | 2025 | Injectafer |
| Sanofi-Aventis U.S. LLC | $15.54 | 2019 | |
| Kestra Medical Technology Services, INC. | $13.68 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kulpreet Barn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.